Hoya saw the highest growth of 0.93% in patent filings in May and 1.27% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.85% and grants by 0.67%. GlobalData’s DataBook provides a comprehensive analysis of Hoya‘s patent filings and grants. Buy the databook here.
Hoya has been focused on protecting inventions in United States(US) with 73 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 35% filings and 24% grants. The United States(US), Japan(JP), China(CN), and European Patent Office(EPO) patent Office are among the top ten patent offices where Hoya is filings its patents. Among the top granted patent authorities, Hoya has 28% of its grants in Japan(JP), 24% in United States(US) and 18% in China(CN).
Shin-Etsu Chemical and AGC could be the strongest competitors for Hoya
Patents related to healthtech and connected patient lead Hoya's portfolio
Hoya has the highest number of patents in healthtech followed by, connected patient and climate change. For healthtech, nearly 44% of patents were filed and 9% of patents were granted in Q2 2024.
Design & manufacturing related patents lead Hoya portfolio followed by paints and inks, and image management
Hoya has highest number of patents in design & manufacturing followed by paints and inks, image management, diagnostic imaging, and petrochemicals. For design & manufacturing, nearly 7% of patents were filed and 24% of patents were granted in Q2 2024.
For comprehensive analysis of Hoya's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.